2016 – 2017 Annual ReportPublished: September 29th 2017
In 2014, Genome Atlantic embarked on an ambitious three-year business plan to meet our region’s growing demand for genomics solutions. We are pleased to share with you our 2016-2017 Annual Report highlighting the final year of this plan and the culmination of a success story that has contributed to a thriving regional biosciences sector.
Genomics plays a key role in enabling innovation in seven sectors and Genome Atlantic is the only organization in Atlantic Canada that is solely focused on helping businesses access DNA-related solutions to thrive and grow.
Simply put, we create good things from life, whether it’s making fish farming environmentally friendly or using marine micro-organisms to de-risk oil and gas exploration. Since our inception in 2000, we have helped to enable more than $90 million in new R&D and over 1,500 person years of employment. The increasing investment from the private sector – currently more than 20% of our portfolio –- speaks to the growing uptake of genomics-based solutions by Atlantic Canadian businesses.
Genome Atlantic is grateful for the generous assistance of the Government of Canada through Genome Canada, the Atlantic Canada Opportunities Agency, and the National Research Council of Canada (Industrial Research Assistance Program) as well as the Province of Newfoundland in supporting our work and helping us contribute to Atlantic Canada’s health and prosperity.
We hope that in reading this Annual Report, you will be as excited as we are about the power and promise of genomics.
Chair, Board of Directors
Steve Armstrong, PhD
President & CEO